Cyclic peptoids show promise as prostate cancer drug
Scientists in the U.S. have developed molecules, termed cyclic peptoids,…
Scientists in the U.S. have developed molecules, termed cyclic peptoids, that block the action of genes that drive the growth of therapy-resistant prostate cancer, according to a new study.